NCT05864326

Brief Summary

This study is a single-center, randomized, two-arm, controlled trial, including women requiring cervical ripening during the process Induction of Labor using Balloon catheter (BC). The primary objective of the study is to determine if the use of heated saline in the BC used for cervical ripening reduces the length of BC duration. Participants will be allocated to :

  • Intervention or warm group: the BC will be filled with heated saline water up to 40° C
  • Standard or room temperature group: the BC will be filled with saline water at room temperature.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
290

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 2, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 18, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

October 16, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2025

Completed
Last Updated

June 5, 2025

Status Verified

June 1, 2025

Enrollment Period

1.6 years

First QC Date

April 2, 2023

Last Update Submit

June 2, 2025

Conditions

Keywords

Cervical ripeningInduction of LaborUnfavorable cervixMechanical method

Outcome Measures

Primary Outcomes (1)

  • To determine if the use of heated saline in the Balloon Catheter (BC), used for cervical ripening, reduces the length of BC duration, defined as the time from the insertion to spontaneous expulsion or artificial removal of the BC.

    Duration of BC (i.e., positioning of the transcervical catheter): interval between insertion and retrieval, either after spontaneous expulsion or artificial retrieval.

    Through study completion, an average of 1.5 years

Secondary Outcomes (7)

  • To evaluate if the use of heated saline compared with room temperature Decreases the length from the start of the induction until the achievement of a favorable cervix (Bishop score >5)

    Through study completion, an average of 1.5 years

  • Decreases the length from the start of the induction until full dilation

    Through study completion, an average of 1.5 years

  • Decreases the length from the start of the induction until the delivery

    Through study completion, an average of 1.5 years

  • Increases the rate and the speed of spontaneous rupture of membranes (ROM) during cervical ripening

    Through study completion, an average of 1.5 years

  • Impacts on the rate of cesarean delivery

    Through study completion, an average of 1.5 years

  • +2 more secondary outcomes

Study Arms (2)

Warm group

EXPERIMENTAL

The Balloon Catheter will be filled with heated saline water up to 40° C

Device: Warm group

Room temperature group

ACTIVE COMPARATOR

the Balloon Catheter will be filled with saline water at room temperature.

Device: Room temperature group

Interventions

The operator will introduce a 14Fr or 18Fr Balloon catheter through the cervical canal, up above the internal orifice using a long Pean clamp and inflate the internal balloon with 30 to 80ml of Heated saline water (NaCl 0.9%) at 40°C - according to the mechanic resistance with a graduated syringe.

Warm group

The operator will introduce a 14Fr or 18Fr Balloon catheter through the cervical canal, up above the internal orifice using a long Pean clamp and inflate the internal balloon with 30 to 80ml of unheated saline water (NaCl 0.9%) - according to the mechanic resistance with a graduated syringe.

Room temperature group

Eligibility Criteria

Age16 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Gestational age at or over 35 weeks
  • Singleton pregnancy
  • Alive fetus
  • Cephalic presentation
  • Maternal age ≥ 16 years

You may not qualify if:

  • Active labor (dilated cervix with spontaneous uterine contractions)
  • Prelabor rupture of membranes
  • \>1 Previous cesarean delivery
  • Fetal malformation leading to a possible obstruction of labor (e.g., hydrocephaly, exteriorized fetal tumors, etc.)
  • Maternal or fetal disease with indication to accelerate labor (start oxytocin stimulation within 6 hours after insertion of the BC (e.g., pre-eclampsia, chorioamnionitis, etc.)\]
  • Counterindication to vaginal delivery
  • Impossibility to give consent to participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpitaux Universitaires de Genève

Geneva, Canton of Geneva, 1205, Switzerland

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Prospective, single-center, randomized, two-arm, controlled trial, including women requiring cervical ripening during the process IOL using Balloon catheter
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 2, 2023

First Posted

May 18, 2023

Study Start

October 16, 2023

Primary Completion

May 30, 2025

Study Completion

May 30, 2025

Last Updated

June 5, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations